Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Specials
Spring Home & Garden Show
Home & Realty
Outdoor Guide
Women
Spring on the Road
Spring Wellness
Premier Home Stylle Tour 2024
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
2024 Auction
2024 Readersâ Choice Awards
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Pfizer
(NY:
PFE
)
28.52
-0.40 (-1.38%)
Streaming Delayed Price
Updated: 11:12 AM EDT, May 17, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Pfizer
< Previous
1
2
...
13
14
15
16
17
18
19
20
21
...
32
33
Next >
Pfizer and BioNTech Announce Positive Early Data From Clinical Trial of Omicron BA.4/BA.5-Adapted Bivalent Booster in Individuals 18 Years and Older
October 13, 2022
From
Pfizer Inc.
Via
Business Wire
Pfizer and BioNTech Receive U.S. FDA Emergency Use Authorization for Omicron BA.4/BA.5-Adapted Bivalent COVID-19 Vaccine Booster in Children 5 Through 11 Years of Age
October 12, 2022
From
Pfizer Inc.
Via
Business Wire
Is Pfizer Stock Still Worth Buying After the Pandemic?
October 12, 2022
Pharmaceutical giant Pfizer (NYSE: PFE) is literally synonymous with COVID-19 vaccines, and as a result, Pfizer stock continues to beat expectations.
Via
MarketBeat
Exposures
COVID-19
VideoKrtoon Offers State Of The Art 2D Animation Services
September 07, 2022
Via
Prodigy
CAPEX.com Launches Share Dealing and ETF Trading Product - CAPEX Invest
October 05, 2022
Bucharest, Romania--(Newsfile Corp. - October 5, 2022) - After previously announcing a zero-commission pre-launch campaign for share dealing, CAPEX.com unveils...
Via
Newsfile
Topics
ETFs
Pfizer Completes Acquisition of Global Blood Therapeutics
October 05, 2022
From
Pfizer Inc.
Via
Business Wire
Pfizer Announces Positive Topline Results from Phase 3 TALAPRO-2 Trial
October 04, 2022
From
Pfizer Inc.
Via
Business Wire
CFund Capital to Present at Blockchain Expo North America October 5-6
October 03, 2022
Markham, ON () October 3, 2022 -- CFund is a professional platform integrating investor education, liquidity provision and crypto asset management.
Via
Prodigy
Topics
Economy
Exposures
Supply Chain
Pfizer Completes Acquisition of Biohaven Pharmaceuticals
October 03, 2022
From
Pfizer Inc.
Via
Business Wire
The Road to Health never ends
September 27, 2022
Via
eTrendy Stock
Exposures
COVID-19
Pfizer and BioNTech Submit Application to U.S. FDA for Emergency Use Authorization of Omicron BA.4/BA.5-Adapted Bivalent Vaccine Booster in Children 5 Through 11 Years of Age
September 26, 2022
From
Pfizer Inc.
Via
Business Wire
Pfizer Declares Fourth-Quarter 2022 Dividend
September 22, 2022
From
Pfizer Inc.
Via
Business Wire
Pfizer to Supply Global Fund Up to 6 Million PAXLOVID™ Treatment Courses for Low-and-Middle-Income Countries
September 22, 2022
From
Pfizer Inc.
Via
Business Wire
Novavax Remains a Risk-On Stock in a Risk-Off Market
September 22, 2022
NVAX is a risk-on stock at a time investors are turning to risk-off assets. This article looks to see if Novavax still presents an opportunity for investors
Via
MarketBeat
Topics
Earnings
Exposures
Financial
Pfizer Invites Public to View and Listen to Webcast of November 1 Conference Call with Analysts
September 20, 2022
From
Pfizer Inc.
Via
Business Wire
Hematological Malignancies Market size is estimated to reach $106.4 billion by 2027 – IndustryARC
September 19, 2022
Continue reading "Hematological Malignancies Market size is estimated to reach $106.4 billion by 2027 – IndustryARC"
Via
Get News
Pfizer Announces Positive Top-Line Results from Phase 3 Study in 20-Valent Pneumococcal Conjugate Vaccine in Infants in the European Union
September 19, 2022
From
Pfizer Inc.
Via
Business Wire
Pfizer Announces Positive Top-Line Results from Phase 3 Trial of Pentavalent Meningococcal Vaccine Candidate (MenABCWY) in Adolescents
September 15, 2022
From
Pfizer Inc.
Via
Business Wire
Pfizer Invites Public to View and Listen to Webcast of Analyst and Investor Call to Review Oral GLP-1 Data Presented at European Association for the Study of Diabetes (EASD) 2022
September 14, 2022
From
Pfizer Inc.
Via
Business Wire
Pfizer Initiates Phase 3 Study of mRNA-Based Influenza Vaccine
September 14, 2022
From
Pfizer Inc.
Via
Business Wire
Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron BA.4/BA.5-Adapted Bivalent COVID-19 Vaccine Booster in European Union
September 12, 2022
From
Pfizer Inc.
Via
Business Wire
Smart Manufacturing Market Share 2022 Size, Key Trends, Future Scope, Global Outlook, Investment Plans and Development Status by 2027
September 09, 2022
Smart Manufacturing Market 2022 | Major Key Players included in this Report are Pfizer , Novartis, Abbott Laboratories and Many More with SWOT Analysis by 2027
Via
SBWire
FDA and EMA Accept Regulatory Submission for Pfizer’s Ritlecitinib for Individuals 12 Years and Older with Alopecia Areata
September 09, 2022
From
Pfizer Inc.
Via
Business Wire
Longwood Fund Announces Longwood Healthcare Leaders, a Webconference for Industry Leaders, on Sept. 21-22, 2022
September 08, 2022
Longwood Fund, an early-stage life science venture firm focused on company creation, will convene several hundred top biotech and pharmaceutical leaders at its Fall Longwood Healthcare Leaders meeting,...
Via
Newswire.com
Exposures
Product Safety
FDA Grants Breakthrough Therapy Designation to Pfizer’s Group B Streptococcus Vaccine Candidate to Help Prevent Infection in Infants Via Immunization of Pregnant Women
September 07, 2022
From
Pfizer Inc.
Via
Business Wire
Pfizer Invites Public to View and Listen to Webcast of Pfizer Discussion at Healthcare Conference
September 06, 2022
From
Pfizer Inc.
Via
Business Wire
Pfizer Invites Public to View and Listen to a Webcast of Pfizer Discussion on Climate Action
September 06, 2022
From
Pfizer Inc.
Via
Business Wire
It All Comes Down To Science And Research With The Efficacy Of Jupiter Wellness’s Lineup Of Skin And Hair Treatment Drugs
September 06, 2022
Today’s consumers are seemingly more health and wellness conscious than ever before. With the increase in social media use, there is even more emphasis placed on personal appearance, with both men and...
Via
TheNewswire.com
Monkeypox vaccine and research related stocks taking center stage (VRAX,GOVX,TNXP,APDN)
September 02, 2022
Via
AB Newswire
Exposures
COVID-19
Pfizer Invites Public to View and Listen to Two Webcasts of Pfizer Discussions at Healthcare Conferences
September 01, 2022
From
Pfizer Inc.
Via
Business Wire
< Previous
1
2
...
13
14
15
16
17
18
19
20
21
...
32
33
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.